The electronic and quantitative structure activity relationship properties of modified telaprevir compounds as HCV NS3 protease inhibitors NA Saleh, AA Elfiky, AA Ezat, WM Elshemey, M Ibrahim Journal of Computational and Theoretical Nanoscience 11 (2), 544-548, 2014 | 28 | 2014 |
Molecular docking investigation of the binding interactions of macrocyclic inhibitors with HCV NS3 protease and its mutants (R155K, D168A and A156V) AA Ezat, NS El-Bialy, HIA Mostafa, MA Ibrahim The Protein Journal 33, 32-47, 2014 | 20 | 2014 |
Theoretical study on modified boceprevir compounds as NS3 protease inhibitors NA Saleh, AA Ezat, AA Elfiky, WM Elshemey, M Ibrahim Journal of Computational and Theoretical Nanoscience 12 (3), 371-375, 2015 | 18 | 2015 |
Novel inhibitors against wild-type and mutated HCV NS3 serine protease: an in silico study AA Ezat, AA Elfiky, WM Elshemey, NA Saleh VirusDisease 30, 207-213, 2019 | 16 | 2019 |
QSAR analysis and molecular docking simulation of suggested peptidomimetic NS3 protease inhibitors HIA Mostafa, NS El-Bialy, AA Ezat, NA Saleh, MA Ibrahim Current Computer-Aided Drug Design 10 (1), 28-40, 2014 | 12 | 2014 |
A comparative study of the efficiency of HCV NS3/4A protease drugs against different HCV genotypes using in silico approaches AA Ezat, WM Elshemey Life sciences 217, 176-184, 2019 | 9 | 2019 |
The discovery of novel antivirals for the treatment of mpox: is drug repurposing the answer? AA Ezat, JM Abduljalil, AM Elghareib, A Samir, AA Elfiky Expert Opinion on Drug Discovery 18 (5), 551-561, 2023 | 7 | 2023 |
Computational approaches to study peptidomimetic and macrocyclic Hepatitis C virus NS3 protease inhibitors AA Ezat, HI Mostafa, N El-Bialy, NA Saleh, MA Ibrahim Journal of Computational and Theoretical Nanoscience 12 (1), 52-59, 2015 | 7 | 2015 |
How helpful were molecular dynamics simulations in shaping our understanding of SARS-CoV-2 spike protein dynamics? JM Abduljalil, AM Elghareib, A Samir, AA Ezat, AA Elfiky International Journal of Biological Macromolecules, 125153, 2023 | 4 | 2023 |
Review 2:" GRP78 binds SARS-CoV-2 Spike protein and ACE2 and GRP78 depleting antibody blocks viral entry and infection in vitro" I Sirakov The MIT Press, 2021 | | 2021 |